XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Stock-Based Compensation Expense (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Schedule of Employee Awards and Non-employee Director Award Plan Activity | During the nine months ended September 30, 2022, the Company granted the following awards (in shares):
|  | Three Months Ended |  |  | Three Months Ended |  |  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, 2022 |  |  | June 30, 2022 |  |  | September 30, 2022 |  |  | September 30, 2022 |
Employee awards: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
RSUs |  |  | 88,415 |  | (1) |  | 2,169,317 |  | (2) |  | 904,435 |  | (5) |  | 3,162,167 |
Market RSUs |  |  | — |  |  |  | 1,359,500 |  | (3) |  | — |  |  |  | 1,359,500 |
Non-employee director RSUs |  |  | — |  |  |  | 360,360 |  | (4) |  | — |  |  |  | 360,360 |
Total awards |  |  | 88,415 |  |  |  | 3,889,177 |  |  |  | 904,435 |  |  |  | 4,882,027 |
_________________________
(1) | RSUs had a weighted average grant date fair value of $2.72 per share, of which 12,800 RSUs had a cliff vesting period of three years and 75,615 RSUs had a vesting period of four years.
(2) | RSUs had a weighted average grant date fair value of $2.95 per share, of which 66,000 had a cliff vesting period of three years and 2,102,717 RSUs had a vesting period of four years.
(3) | Market RSUs had a grant date fair value of $6.10 per share and will vest on May 10, 2025 provided the closing price of the Company’s common stock on such vesting date is not less than the closing price on May 10, 2022. The number of shares delivered on the vesting date is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above.
(4) | RSUs had a weighted average grant date fair value of $2.95 per share and vested immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service, such as resignation, retirement or death.
(5) | RSUs had a weighted average grant date fair value of $3.78 per share, of which 357,000 RSUs had a cliff vesting period of two years, 320,400 RSUs had a cliff vesting period of three years, and 227,035 RSUs had a vesting period of four years.
Stock Based Compensation Expense Recognized in Condensed Consolidated Statements of Operations | Total stock-based compensation expense recognized in the condensed consolidated statements of operations as cost of goods sold, cost of revenue – collaborations and services, research and development and selling, general and administrative expense for the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
RSUs and options |  | $ | 3,475 |  |  | $ | 2,983 |  |  | $ | 10,358 |  |  | $ | 8,628 |
Employee stock purchase plan |  |  | 147 |  |  |  | 196 |  |  |  | 492 |  |  |  | 412 |
Total stock compensation expense |  | $ | 3,622 |  |  | $ | 3,179 |  |  | $ | 10,850 |  |  | $ | 9,040 |

X
- Definition Schedule of share based compensation employee stock purchase plan and non employee director stock award plan activity. + References No definition available. + Details
Name: | mnkd_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanAndNonEmployeeDirectorStockAwardPlanActivityTableTextBlock
Namespace Prefix: | mnkd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration